NCT04183218 - Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 23, 2019

Primary Completion Date

January 6, 2024

Study Completion Date

May 2, 2024

Conditions

Clinical Stage 0 Esophageal Adenocarcinoma AJCC V8Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC V8Clinical Stage I Esophageal Adenocarcinoma AJCC V8Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC V8Clinical Stage II Esophageal Adenocarcinoma AJCC V8Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC V8Clinical Stage IIA Esophageal Adenocarcinoma AJCC V8Clinical Stage IIB Esophageal Adenocarcinoma AJCC V8Clinical Stage III Esophageal Adenocarcinoma AJCC V8Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC V8Localized Esophageal CarcinomaLocalized Lung CarcinomaPathologic Stage 0 Esophageal Adenocarcinoma AJCC V8Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC V8Pathologic Stage I Esophageal Adenocarcinoma AJCC V8Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC V8Pathologic Stage IA Esophageal Adenocarcinoma AJCC V8Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC V8Pathologic Stage IB Esophageal Adenocarcinoma AJCC V8Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC V8Pathologic Stage IC Esophageal Adenocarcinoma AJCC V8Pathologic Stage II Esophageal Adenocarcinoma AJCC V8Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC V8Pathologic Stage IIA Esophageal Adenocarcinoma AJCC V8Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC V8Pathologic Stage IIB Esophageal Adenocarcinoma AJCC V8Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC V8Pathologic Stage III Esophageal Adenocarcinoma AJCC V8Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC V8Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC V8Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC V8Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC V8Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC V8Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC V8Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC V8Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC V8Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC V8Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC V8Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC V8Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC V8Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC V8Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC V8Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC V8Stage 0 Lung Cancer AJCC V8Stage I Lung Cancer AJCC V8Stage IA1 Lung Cancer AJCC V8Stage IA2 Lung Cancer AJCC V8Stage IA3 Lung Cancer AJCC V8Stage IB Lung Cancer AJCC V8Stage II Lung Cancer AJCC V8Stage IIA Lung Cancer AJCC V8Stage IIB Lung Cancer AJCC V8Stage III Lung Cancer AJCC V8Stage IIIA Lung Cancer AJCC V8Stage IIIB Lung Cancer AJCC V8Stage IIIC Lung Cancer AJCC V8

Interventions

PROCEDURE

Biospecimen Collection

Undergo biospecimen collection

DEVICE

Cardiac Event Monitor

Receive cardiac monitor

OTHER

Chemoradiotherapy

Undergo CRT

RADIATION

Radiation Therapy

Undergo RT

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale